The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Oxidative Stress in Diabetes and Alzheimer's Disease
Open accessAbstract
Oxidative stress plays a major role in diabetes as well as in Alzheimer's disease and other related neurological diseases. Intracellular oxidative stress arises due to the imbalance in the production of reactive oxygen/reactive nitrogen species and cellular antioxidant defense mechanisms. In turn, the excess reactive oxygen/reactive nitrogen species mediate the damage of proteins and nucleic acids, which have been shown to have direct and deleterious consequences in diabetes and Alzheimer's disease. Oxidative stress also contributes to the production of advanced glycation end products through glycoxidation and lipid peroxidation. The advanced glycation end products and lipid peroxidation products are ubiquitous to diabetes and Alzheimer's disease and serve as markers of disease progression in both disorders. Antioxidants and advanced glycation end products inhibitors, either induced endogenously or exogenously introduced, may counteract with the deleterious effects of the reactive oxygen/reactive nitrogen species and thereby, in prevention or treatment paradigms, attenuate or substantially delay the onset of these devastating pathologies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., et al. (2000) · Nature · doi:10.1038/35008121 · Cited by 4,277
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885
Self-citationMitochondrial abnormalities in Alzheimer's disease
Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03017.2001 · Cited by 1,367
Self-citationIron accumulation in Alzheimer disease is a source of redox-generated free radicals
Smith, M. A., Harris, P. L. R., Sayre, L. M., & Perry, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9866 · Cited by 1,355
Self-citationUnderstanding RAGE, the receptor for advanced glycation end products
Bierhaus, A., Humpert, P. M., Morcos, M., Wendt, T., Chavakis, T., Arnold, B., Stern, D. M., & Nawroth, P. P. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0688-7 · Cited by 1,297
Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease
Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239
Self-citationSayre, L. M., Zelasko, D. A., Harris, P. L. R., Perry, G., Salomon, R. G., & Smith, M. A. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052092.x · Cited by 1,007
Self-citationReddy, P. H., & Beal, M. F. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.12.002 · Cited by 975
Protein Glycation, Diabetes, and Aging
Ulrich, P. (2001) · Recent Progress in Hormone Research · doi:10.1210/rp.56.1.1 · Cited by 810
A “mitochondrial cascade hypothesis” for sporadic Alzheimer’s disease
Swerdlow, R. H., & Khan, S. M. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2003.12.045 · Cited by 758
Advanced Maillard reaction end products are associated with Alzheimer disease pathology.
Smith, M. A., Taneda, S., Richey, P. L., Miyata, S., Yan, S. D., Stern, D., Sayre, L. M., Monnier, V. M., & Perry, G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5710 · Cited by 714
Self-citationProtein Oxidation in Aging and Age‐Related Diseases
Stadtman, E. R. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb05632.x · Cited by 660
Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress.
Yan, S. D., Chen, X., Schmidt, A. M., Brett, J., Godman, G., Zou, Y. S., Scott, C. W., Caputo, C., Frappier, T., & Smith, M. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7787 · Cited by 565
Self-citationSayre, L. M., Perry, G., Harris, P. L. R., Liu, Y., Schubert, K. A., & Smith, M. A. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0740270.x · Cited by 540
Self-citationAbnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease.
McShea, A., Harris, P. L. R., Webster, K. R., Wahl, A. F., & Smith, M. A. (1997) · Europe PMC (PubMed Central) · Cited by 468
Self-citationRadical AGEing in Alzheimer's disease
Smith, M. A., Sayre, L. M., Monnier, V. M., & Perry, G. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93897-7 · Cited by 462
Self-citationYan, S. F., Ramasamy, R., & Schmidt, A. M. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0786 · Cited by 434
Alzheimer's disease: the two-hit hypothesis
Zhu, X., Raina, A. K., Perry, G., & Smith, M. A. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00707-0 · Cited by 426
Self-citationHeme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease.
Smith, M. A., Kutty, R. K., Richey, P. L., Yan, S. D., Stern, D., Chader, G. J., Wiggert, B. O., Petersen, R. B., & Perry, G. L. (1994) · PubMed · Cited by 424
Self-citationThe Role of Mitogen-Activated Protein Kinase Pathways in Alzheimer’s Disease
Zhu, X., Lee, H.-G., Raina, A. K., Perry, G., & Smith, M. A. (2002) · Neurosignals · doi:10.1159/000067426 · Cited by 391
Self-citationRedox-active iron mediates amyloid-β toxicity
Rottkamp, C. A., Raina, A. K., Zhu, X., Gaier, E., Bush, A. I., Atwood, C. S., Chevion, M., Perry, G., & Smith, M. A. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00494-9 · Cited by 375
Self-citationAdvanced glycation endproducts: what is their relevance to diabetic complications?
Ahmed, N., & Thornalley, P. J. (2007) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00595.x · Cited by 371
Protein Adducts Generated from Products of Lipid Oxidation: Focus on HNE and ONE
Sayre, L. M., Lin, D., Yuan, Q., Zhu, X., & Tang, X. (2006) · Drug Metabolism Reviews · doi:10.1080/03602530600959508 · Cited by 365
Self-citationCauses of oxidative stress in Alzheimer disease
Zhu, X., Su, B., Wang, X., Smith, M. A., & Perry, G. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7218-4 · Cited by 336
Self-citationAHMED, N., ARGIROV, O. K., MINHAS, H. S., CORDEIRO, C. A. A., & THORNALLEY, P. J. (2002) · Biochemical Journal · doi:10.1042/bj3640001 · Cited by 336
Zhu, X., Castellani, R. J., Takeda, A., Nunomura, A., Atwood, C. S., Perry, G., & Smith, M. A. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00342-6 · Cited by 309
Self-citationAlzheimer disease, the two-hit hypothesis: An update
Zhu, X., Lee, H.-G., Perry, G., & Smith, M. A. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.10.014 · Cited by 292
Self-citationInhibitors of the Maillard reaction and AGE breakers as therapeutics for multiple diseases
Reddy, V. P., & Beyaz, A. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.05.016 · Cited by 266
Self-citationABAD enhances Aβ‐induced cell stress via mitochondrial dysfunction
Takuma, K., Yao, J., Huang, J., Xu, H., Chen, X., Luddy, J., Trillat, A.-C., Stern, D. M., Arancio, O., & Yan, S. S. (2005) · The FASEB Journal · doi:10.1096/fj.04-2582fje · Cited by 252
Premkumar, D. R. D., Smith, M. A., Richey, P. L., Petersen, R. B., Castellani, R., Kutty, R. K., Wiggert, B., Perry, G., & Kalaria, R. N. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65031399.x · Cited by 211
Self-citationRAGE: A Potential Target for Aβ-Mediated Cellular Perturbation in Alzheimers Disease
Yan, S., Chen, X., Walker, D., Schmidt, A., Arancio, O., & Lue, L.-F. (2007) · Current Molecular Medicine · doi:10.2174/156652407783220741 · Cited by 207
Lipid Peroxidation and Antioxidant Enzyme Activities in Vascular and Alzheimer Dementias
Casado, Á., Encarnación López-Fernández, M., Concepción Casado, M., & de La Torre, R. (2008) · Neurochemical Research · doi:10.1007/s11064-007-9453-3 · Cited by 206
Takeda, A., Smith, M. A., Avilá, J., Nunomura, A., Siedlak, S. L., Zhu, X., Perry, G., & Sayre, L. M. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751234.x · Cited by 203
Self-citationTamagno, E., Robino, G., Obbili, A., Bardini, P., Aragno, M., Parola, M., & Danni, O. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(02)00059-6 · Cited by 201
Diau, G.-Y., Hsieh, A. T., Sarkadi-Nagy, E. A., Wijendran, V., Nathanielsz, P. W., & Brenna, J. T. (2005) · BMC Medicine · doi:10.1186/1741-7015-3-11 · Cited by 199
Castellani, R. J., Harris, P. L. R., Sayre, L. M., Fujii, J., Taniguchi, N., Vitek, M. P., Founds, H., Atwood, C. S., Perry, G., & Smith, M. A. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00570-6 · Cited by 198
Self-citationMoreira, P. I., Harris, P. L. R., Zhu, X., Santos, M. S., Oliveira, C. R., Smith, M. A., & Perry, G. (2007) · Journal of Alzheimer's Disease · doi:10.3233/jad-2007-12210 · Cited by 196
Self-citationBooth, A. A., Khalifah, R. G., & Hudson, B. G. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0366 · Cited by 191
Ectopic localization of phosphorylated histone H3 in Alzheimer's disease: a mitotic catastrophe?
Ogawa, O., Zhu, X., Lee, H.-G., Raina, A., Obrenovich, M. E., Bowser, R., Ghanbari, H. A., Castellani, R. J., Perry, G., & Smith, M. A. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0684-3 · Cited by 175
Self-citationAtherosclerosis and diabetes: The rage connection
Schmidt, A. M., & Stern, D. (2000) · Current Atherosclerosis Reports · doi:10.1007/s11883-000-0082-4 · Cited by 167
4-Oxo-2-nonenal Is Both More Neurotoxic and More Protein Reactive than 4-Hydroxy-2-nonenal
Lin, D., Lee, H.-G., Liu, Q., Perry, G., Smith, M. A., & Sayre, L. M. (2005) · Chemical Research in Toxicology · doi:10.1021/tx050080q · Cited by 164
Self-citationOXIDATIVE STRESS, AND CELLULAR STRESS RESPONSE IN DIABETIC NEPHROPATHY
Calabrese, V., Mancuso, C., Sapienza, M. A., Guagliano, E., Puleo, E., Calafato, S., Finocchiaro, M., Mangiameli, A., Mauro, M. D., Stella, A. M. G., et al. (2005) · Cell Stress and Chaperones · doi:10.1379/csc-270.1 · Cited by 163
The Role of AGEs and AGE Inhibitors in Diabetic Cardiovascular Disease
Thomas, M., Baynes, J., Thorpe, S., & Cooper, M. (2005) · Current Drug Targets · doi:10.2174/1389450054021873 · Cited by 159
Tan, K. C. B., Shiu, S. W. M., Chow, W. S., Leng, L., Bucala, R., & Betteridge, D. J. (2006) · Diabetologia · doi:10.1007/s00125-006-0394-1 · Cited by 158
Soluble RAGE in type 2 diabetes: Association with oxidative stress
Devangelio, E., Santilli, F., Formoso, G., Ferroni, P., Bucciarelli, L. G., Michetti, N., Clissa, C., Ciabattoni, G., Consoli, A., & Davì, G. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.03.015 · Cited by 155
Effect of the lipid peroxidation product acrolein on tau phosphorylation in neural cells
Gómez‐Ramos, A., Díaz‐Nido, J., Smith, M. A., Perry, G. L., & Ávila, J. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10525 · Cited by 152
Self-citationRamasamy, R., Yan, S. F., Herold, K. C., Clynes, R., & Schmidt, A. M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1433.056 · Cited by 147
Cysteine modification by lipid peroxidation products inhibits protein disulfide isomerase.
Carbone, D., Doorn, J., Kiebler, Z., & Petersen, D. (2005) · Chemical Research in Toxicology · doi:10.1021/tx050078z · Cited by 144
Carnosine: A Versatile Antioxidant and Antiglycating Agent
Reddy, V. P., Garrett, M. R., Perry, G. L., & Smith, M. A. (2005) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2005.18.pe12 · Cited by 144
Self-citationSignaling kinases modulated by 4-hydroxynonenal
Leonarduzzi, G., Robbesyn, F., & Poli, G. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.08.027 · Cited by 139
Neuronal oxidative damage from activated innate immunity is EP2 receptor‐dependent
Montine, T. J., Milatović, D., Gupta, R. C., Vályi-Nagy, T., Morrow, J. D., & BREYER, R. M. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01157.x · Cited by 135
Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations
Liu, Q., Smith, M. A., Ávila, J., DeBernardis, J. F., Kansal, M. M., Takeda, A., Zhu, X., Nunomura, A., Honda, K., Moreira, P. I., et al. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.11.005 · Cited by 130
Self-citationWataya, T., Nunomura, A., Smith, M. A., Siedlak, S. L., Harris, P. L. R., Shimohama, S., Szweda, L. I., Kaminski, M. A., Ávila, J., Price, D. L., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110913200 · Cited by 128
Self-citationHydroxynonenal, toxic carbonyls, and Alzheimer disease
Liu, Q., Raina, A. K., Smith, M. A., Sayre, L. M., & Perry, G. L. (2003) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(03)00025-6 · Cited by 120
Self-citationLeeuwenburgh, C., Hansen, P. A., Shaish, A., Holloszy, J. O., & Heinecke, J. W. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.274.2.r453 · Cited by 111
Involvement of maillard reactions in Alzheimer disease
Reddy, V. P., Obrenovich, M. E., Atwood, C., Perry, G. L., & Smith, M. A. (2002) · Neurotoxicity Research · doi:10.1080/1029840290007321 · Cited by 110
Self-citationCould Carnosine or Related Structures Suppress Alzheimer's Disease?
Hipkiss, A. R. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-11210 · Cited by 107
Yamagishi, S., Nakamura, K., Matsui, T., Noda, Y., & Imaizumi, T. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208783597416 · Cited by 104
Liu, Z., Minkler, P. E., & Sayre, L. M. (2003) · Chemical Research in Toxicology · doi:10.1021/tx0300030 · Cited by 102
Novel Inhibitors of Advanced Glycation Endproducts (Part II)
Rahbar, S., Yerneni, K. K. V., Scott, S., Gonzales, N., & Lalezari, I. (2000) · Molecular Cell Biology Research Communications · doi:10.1006/mcbr.2000.0239 · Cited by 101
Trans‐4‐hydroxy‐2‐hexenal is a neurotoxic product of docosahexaenoic (22:6; n‐3) acid oxidation
Long, E. K., Murphy, T. C., Leiphon, L. J., Watt, J. A., Morrow, J. D., Milne, G. L., Howard, J. R. H., & Picklo, M. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05175.x · Cited by 100
Age-dependent changes of glyoxalase I expression in human brain
Kuhla, B., Boeck, K., Lüth, H., Schmidt, A., Weigle, B., Schmitz, M., Ogunlade, V., Münch, G. W., & Arendt, T. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.04.006 · Cited by 95
Effects of OPB‐9195, anti‐glycation agent, on experimental diabetic neuropathy
Wada, R., Nishizawa, Y., Yagihashi, N., Takeuchi, M., Ishikawa, Y., YASUMURA, K., Nakano, M., & Yagihashi, S. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00826.x · Cited by 93
Tan, K. C. B., Chow, W.-S., Tso, A. W. K., Xu, A., Tse, H., Hoo, R. L. C., Betteridge, D. J., & Lam, K. S. L. (2007) · Diabetologia · doi:10.1007/s00125-007-0759-0 · Cited by 91
Nakabeppu, Y., Tsuchimoto, D., Ichinoe, A., Ohno, M., Ide, Y., Hirano, S., YOSHIMURA, D., Tominaga, Y., Furuichi, M., & Sakumi, K. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1293.011 · Cited by 89
Oxidative damage in cultured human olfactory neurons from Alzheimer's disease patients
Ghanbari, H. A., Ghanbari, K., Harris, P. L. R., Jones, P. K., Kubat, Z., Castellani, R. J., Wolozin, B. L., Smith, M. A., & Perry, G. L. (2004) · Aging Cell · doi:10.1111/j.1474-9728.2004.00083.x · Cited by 89
Self-citationStadler, K., Bonini, M. G., Dallas, S., Jiang, J., Radí, R., Mason, R. P., & Kadiiska, M. B. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.06.023 · Cited by 88
Webster, J. A., Urban, C., Berbaum, K., Loske, C., Alpár, A., Gärtner, U., de Arriba, S. G., Arendt, T., & Münch, G. W. (2005) · Neurotoxicity Research · doi:10.1007/bf03033780 · Cited by 86
Buetler, T. M., Leclerc, E., Baumeyer, A., Latado, H., Newell, J. W., Adolfsson, O., Parisod, V., Richoz, J., Maurer, S., Foata, F., et al. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700101 · Cited by 82
Vasdev, S., Gill, V. D., & Singal, P. K. (2007) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-007-0039-0 · Cited by 82
Rabbani, N., & Thornalley, P. J. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1433.043 · Cited by 82
Oxidative damage in the olfactory system in Alzheimer's disease
Perry, G. L., Castellani, R. J., Smith, M. A., Harris, P. L. R., Kubat, Z., Ghanbari, K., Jones, P. K., Cordone, G., Tabaton, M., Wolozin, B. L., et al. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0761-7 · Cited by 81
Self-citationStewart, B., Doorn, J., & Petersen, D. (2007) · Chemical Research in Toxicology · doi:10.1021/tx700106v · Cited by 78
Takeda, A., Yasuda, T., Miyata, T., Goto, Y., Wakai, M., Watanabe, M., Yasuda, Y., Horie, K., Inagaki, T., Doyu, M., et al. (1998) · Acta Neuropathologica · doi:10.1007/s004010050839 · Cited by 78
Prevention and Reversal of Diabetic Nephropathy in db/db Mice Treated with Alagebrium (ALT-711)
Peppa, Μ., Brem, H., Cai, W., Zhang, J.-G., Basgen, J. M., Li, Z., Vlassara, H., & Uribarri, J. (2006) · American Journal of Nephrology · doi:10.1159/000095786 · Cited by 74
Takeuchi, M., & Makita, Z. (2001) · Current Molecular Medicine · doi:10.2174/1566524013363735 · Cited by 71
Synold, T. W., Xi, B., Wuenschell, G. E., Tamae, D., Figarola, J. L., Rahbar, S., & Termini, J. S. (2008) · Chemical Research in Toxicology · doi:10.1021/tx800224y · Cited by 69
Prevention and Treatment of Alzheimer Disease and Aging: Antioxidants
Liu, Q., Xie, F., Rolston, R. K., Moreira, P. I., Nunomura, A., Zhu, X., Smith, M. A., & Perry, G. L. (2007) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955707779802552 · Cited by 68
Self-citationMechanisms of 4-hydroxynonenal-induced neuronal microtubule dysfunction
Neely, M. D., Boutté, A. M., Milatović, D., & Montine, T. J. (2005) · Brain Research · doi:10.1016/j.brainres.2004.12.027 · Cited by 65
Smith, M. A., Siedlak, S. L., Richey, P. L., Nagaraj, R. H., Elhammer, Å. P., & Perry, G. L. (1996) · Brain Research · doi:10.1016/0006-8993(95)01473-x · Cited by 65
Self-citationInflammation and the Redox‐sensitive AGE–RAGE Pathway as a Therapeutic Target in Alzheimer's Disease
Maczurek, A. E., Shanmugam, K., & Münch, G. W. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1433.026 · Cited by 64
Increased 3-nitrotyrosine in brains of Apo E-deficient mice
Matthews, R. T., & Beal, M. F. (1996) · Brain Research · doi:10.1016/0006-8993(95)01576-0 · Cited by 62
Mitochondrial genomic contribution to mitochondrial dysfunction in Alzheimer's disease
Onyango, I. G., Khan, S. M., Miller, B. B., Swerdlow, R. H., Trimmer, P. A., & Bennett, J. P. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9210 · Cited by 60
Yan, S. F., Barile, G. R., D’Agati, V. D., Yan, S. D., Ramasamy, R., & Schmidt, A. M. (2007) · Current Diabetes Reports · doi:10.1007/s11892-007-0024-4 · Cited by 60
Larbig, G., Pickhardt, M., Lloyd, D. G., & Schmidt, B. (2007) · Current Alzheimer Research · doi:10.2174/156720507781077250 · Cited by 58
Adrover, M., Vilanova, B., Frau, J., Muñoz, F., & Donoso, J. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.04.002 · Cited by 57
Neuronal polo-like kinase in Alzheimer disease indicates cell cycle changes
Harris, P. L. R., Zhu, X., Pamies, C., Rottkamp, C. A., Ghanbari, H. A., McShea, A., Feng, Y., Ferris, D. K., & Smith, M. A. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00218-9 · Cited by 55
Self-citationSanta‐María, I., Smith, M. A., Perry, G. L., Hernández, F., Ávila, J., & Moreno, F. J. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.11.024 · Cited by 47
Self-citationImmunochemical detection of Nε-(carboxyethyl)lysine using a specific antibody
Nagai, R., Fujiwara, Y., Mera, K., Yamagata, K., Sakashita, N., & Takeya, M. (2008) · Journal of Immunological Methods · doi:10.1016/j.jim.2007.12.020 · Cited by 46
Cross-link breakers as a new therapeutic approach to cardiovascular disease
Susic, D. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350853 · Cited by 44
DNA-glycation leads to depurination by the loss of N2-carboxyethylguanine in vitro.
Seidel, W., & Pischetsrieder, M. (1998) · PubMed · Cited by 39
Spiteller, G. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1433.031 · Cited by 37
Diabetes mellitus and Alzheimer's disease: glycation as a biochemical link
Smith, M. A., Sayre, L. M., & Perry, G. (1996) · Diabetologia · doi:10.1007/bf00403972 · Cited by 36
Self-citationProtein Aggregation in Alzheimers Disease and Other Neoropathological Disorders
Dimakopoulos, A. C. (2005) · Current Alzheimer Research · doi:10.2174/1567205052772795 · Cited by 33
Annangudi, S. P., Deng, Y., Gu, X., Zhang, W., Crabb, J. W., & Salomon, R. G. (2008) · Chemical Research in Toxicology · doi:10.1021/tx8000303 · Cited by 28
Sell, D. R., Strauch, C., Shen, W., & Monnier, V. M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1433.065 · Cited by 24
sRAGE and esRAGE are not Associated with Peripheral or Autonomic Neuropathy in Type 2 Diabetes
Humpert, P. M., Papadopoulos, G., Schaefer, K. K., Djuric, Z., Konrāde, I., Morcos, M., Nawroth, P. P., & Bierhaus, A. (2007) · Hormone and Metabolic Research · doi:10.1055/s-2007-993155 · Cited by 24
Investigation of DNA–Protein Cross‐Link Formation between Lysozyme and Oxanine by Mass Spectrometry
Chen, H. C., Chiu, W., Lin, W., & Yang, S. (2008) · ChemBioChem · doi:10.1002/cbic.200700686 · Cited by 15
The Role of Oxidative Damage to Nucleic Acids in the Pathogenesis of Neurological Disease
Reddy, V. P., Beyaz, A., Perry, G. L., Cooke, M. S., Sayre, L. M., & Smith, M. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-72974-9_10 · Cited by 12
Self-citationChen, H. C., Hsieh, C.-J., Shen, L., & Chang, C. (2007) · Biochemistry · doi:10.1021/bi0620398 · Cited by 11
Emerging drugs for diabetic nephropathy
Bruno, S., Cattaneo, D., Perico, N., & Remuzzi, G. (2005) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.10.4.747 · Cited by 11
AGE and RAGE inhibitors in the treatment of diabetic retinopathy
Bhatwadekar, A. D., & Stitt, A. W. (2007) · Expert Review of Ophthalmology · doi:10.1586/17469899.2.1.105 · Cited by 7
Two Hits and You’re Out? A Novel Mechanistic Hypothesis of Alzheimer Disease
Zhu, X., Perry, G. L., & Smith, M. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-72076-0_19 · Cited by 4
Self-citationAntioxidant Therapies in the Prevention and Treatment of Alzheimer Disease
Nunomura, A., Zhu, X., Moreira, P. I., Perry, G. L., & Smith, M. A. (2005) · Oxidative stress and disease · doi:10.1201/9781420026559.ch7 · Cited by 2
Self-citation
Cited by
Current and future treatments for Alzheimer's disease
Yiannopoulou, K. G., & Papageorgiou, S. G. (2013) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285612461679 · Cited by 677
Protein carbonylation as a major hallmark of oxidative damage: Update of analytical strategies
Fedorova, M., Bollineni, R. C., & Hoffmann, R. (2014) · Mass Spectrometry Reviews · doi:10.1002/mas.21381 · Cited by 516
How does diabetes accelerate Alzheimer disease pathology?
Sims-Robinson, C., Kim, B., Rosko, A., & Feldman, E. L. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.130 · Cited by 492
Redox Regulation in Cancer: A Double‐edged Sword with Therapeutic Potential
Acharya, A., Das, I., Chandhok, D., & Saha, T. (2010) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.3.1.10095 · Cited by 486
Brain metabolic dysfunction at the core of Alzheimer's disease
de la Monte, S. M., & Tong, M. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.012 · Cited by 461
Metadata
- Authors
- Reddy, V. P., Zhu, X., Perry, G., & Smith, M. A.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2009-04-17
- Volume
- 16
- Issue
- 4
- Pages
- 763-774
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1597763516
- Cited by
- 280
- References
- 105
- FWCI
- 12.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.